Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
Cardiovascular Systems, Inc. (NASDAQ:CSII - Get Rating) saw a significant growth in short interest in the month of July. As of July 31st, there was short interest totalling 1,450,000 shares, a growth of 17.9% from the July 15th total of 1,230,000 shares. Based on an average trading volume of 345,500 shares, the short-interest ratio is presently 4.2 days. Approximately 4.3% of the shares of the company are short sold. Insider Buying and Selling at Cardiovascular Systems
In other news, CFO Jeffrey S. Points purchased 3,000 shares of the firm's stock in a transaction on Friday, May 20th. The stock was bought at an average cost of $14.50 per share, for a total transaction of $43,500.00. Following the completion of the acquisition, the chief financial officer now directly owns 109,312 shares of the company's stock, valued at $1,585,024. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 3.00% of the company's stock. Institutional Investors Weigh In On Cardiovascular Systems
Several hedge funds have recently made changes to their positions in the stock. Signaturefd LLC lifted its stake in Cardiovascular Systems by 8,110.3% during the first quarter. Signaturefd LLC now owns 2,381 shares of the medical device company's stock worth $54,000 after purchasing an additional 2,352 shares during the period. Acadian Asset Management LLC lifted its stake in Cardiovascular Systems by 294.7% during the fourth quarter. Acadian Asset Management LLC now owns 2,684 shares of the medical device company's stock worth $50,000 after purchasing an additional 2,004 shares during the period. PNC Financial Services Group Inc. lifted its stake in Cardiovascular Systems by 32.1% during the first quarter. PNC Financial Services Group Inc. now owns 3,025 shares of the medical device company's stock worth $68,000 after purchasing an additional 735 shares during the period. Nisa Investment Advisors LLC lifted its stake in Cardiovascular Systems by 54.3% during the first quarter. Nisa Investment Advisors LLC now owns 3,495 shares of the medical device company's stock worth $79,000 after purchasing an additional 1,230 shares during the period. Finally, Point72 Hong Kong Ltd bought a new position in Cardiovascular Systems during the fourth quarter worth about $74,000. Institutional investors own 91.24% of the company's stock. Cardiovascular Systems Stock Up 2.1 %
Shares of NASDAQ CSII traded up $0.35 during mid-day trading on Friday, hitting $16.64. The company had a trading volume of 177,636 shares, compared to its average volume of 291,714. The company has a quick ratio of 5.19, a current ratio of 6.05 and a debt-to-equity ratio of 0.08. The business's 50-day simple moving average is $15.20 and its 200-day simple moving average is $17.76. Cardiovascular Systems has a 12 month low of $13.41 and a 12 month high of $38.52. About Cardiovascular Systems (Get Rating)
Cardiovascular Systems, Inc, a medical device company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products, which are catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products.Recommended StoriesGet a free copy of the StockNews.com research report on Cardiovascular Systems (CSII)2 Important Retail Stock Battles to WatchMarketBeat: Week in Review 8/8 - 8/12What Is WallStreetBets and What Stocks Are They Targeting?Institutions And Analysts Propel Jack In The Box Higher Can You Guess Which EV Stock Is Beating Tesla ?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cardiovascular Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardiovascular Systems wasn't on the list.
While Cardiovascular Systems currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:
Tom remains optimistic about investors’ prospects going forward, even as the market reacts to the words of Fed Chair Jerome Powell about “pain ahead.”
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.